Sort
326,823 grants matching “clinical trial”
1/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD)
$1,841,946Manesh R Patel · Duke University · UH3 · FY2025 · HL
Case/UHC Center for AIDS Research
$1,841,815Jonathan Karn · Case Western Reserve University · P30 · FY2012 · AI
Early Treatment of ALS with Nutrition and NIPPV
$1,841,793Edward J Kasarskis · University Of Kentucky · R01 · FY2006 · NS
PROSTATE CANCER CLINICAL TRIALS GROUP: WAYNE STATE UNIVERSITY/KARMANOS CANCER INSTITUTE
$1,841,670Wayne State University · · FY2009 · Department of Defense
Units for HIV/AIDS Clinical Trials Networks
$1,841,563Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · U01 · FY2007 · AI
Understanding the causes of second episode cryptococcal meningitis to improve diagnosis and treatment
$1,841,519Nathan Bahr · University Of Minnesota · RF1 · FY2025 · NS
Asthma and Nocturnal Hypoxemia in Sickle Cell Anemia
$1,841,516Michael Rutledge Debaun · Washington University · R01 · FY2008 · HL
Hopkins Center for Eliminate Cardiovascular Health Disparities
$1,841,361Lisa A Cooper · Johns Hopkins University · P50 · FY2010 · HL
Pediatric Heart Disease Clinical Research Network - DCC
$1,841,234New England Research Institutes, Inc. · U01 · FY2002 · HL
Clinical trial of trimethoprim-sulfamethoxazole or chloroquine in adults on ART
$1,841,146Miriam K Laufer · University Of Maryland Baltimore · U01 · FY2012 · AI
Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease
$1,840,995William T Dauer · University Of Michigan At Ann Arbor · P50 · FY2016 · NS
Translational Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa
$1,840,747William A. Beltran · University Of Pennsylvania · R24 · FY2015 · EY
Cefalu: Overall; Botanicals and Metabolic Resiliency (Cefalu)
$1,840,664William T. Cefalu · Lsu Pennington Biomedical Research Ctr · P50 · FY2015 · AT
Consortium of Eosinophilic Gastrointestinal Disease Researchers
$1,840,643Marc E. Rothenberg · Cincinnati Childrens Hosp Med Ctr · U54 · FY2023 · AI
Influenza and Emerging Infectious Diseases
$1,840,538Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
DNA Sequencing and FACS Core Facilities
$1,840,527Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
General Clinical Research Center
$1,840,430David A Brenner · University Of California, San Diego · M01 · FY2010 · RR
1/2 IMPRoving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)
$1,840,312Manesh R Patel · Duke University · UH3 · FY2024 · HL
Manufacture of an intracerebroventricular Enzyme Replacement Therapy for CLN1 Batten Disease
$1,840,246Sean Ekins · Collaborations Pharmaceuticals, Inc. · SB1 · FY2024 · NS
3D Bioprinting of human native-like tissues as disease-in-a-dish models for drug discovery
$1,840,012Marc Ferrer-Alegre · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Biologic Response of Menopausal Women to 17B-Estradiol
$1,839,972Howard N Hodis · University Of Southern California · R01 · FY2006 · AG
2/2 REACT-AF: Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation
$1,839,921Daniel F Hanley · Johns Hopkins University · U24 · FY2022 · HL
Emory University Lung Cancer SPORE
$1,839,911Suresh S Ramalingam · Emory University · P50 · FY2023 · CA
Emory University Lung Cancer SPORE
$1,839,911Suresh S Ramalingam · Emory University · P50 · FY2022 · CA
PACT
$1,839,728John Keach · University Of Wisconsin-Madison · N01 · FY2014 · HL